Clene Inc CNM-Au8 ALS Program Update Call Transcript
Good day ladies and gentlemen, and welcome to Clene's ALS program update conference call. (Operator Instruction) I would now like to introduce your host for today's conference, Rob Etherington. You may begin.
Thank you for joining us on today's conference call. We hope that you had a great Thanks giving last week with your family and friends. I'm Rob Etherington, CEO of Clene Nanomedicine. Join me on this call.
Doctor Benjamin Greenberg, the head of Medical for Clean, Vice Chair of Clinical and Translational Research, at his university, Doctor Jinsy Andrews, the Director of the ALS Center in the Department of Neurology at NYU Grossman School of Medicine and the principal investigator of our NAH sponsored EAP trial of which we are about to speak to. Michael Hodgkins, the Chief Development Officer; and Morgan Brown, our Chief Financial Officer.
Thank you. During today's presentation, we'll make several forward-looking statements. We'll have no obligation to update
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
